Comparative Pharmacology
Head-to-head clinical analysis: EXIDINE versus HIBICLENS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EXIDINE versus HIBICLENS.
EXIDINE vs HIBICLENS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
EXIDINE (chlorhexidine gluconate oral rinse) is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged bacterial cell walls, causing leakage of intracellular components and cell death.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged cell wall components, causing leakage of cytoplasmic contents and precipitation of proteins. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria, fungi, and some viruses.
Apply topically to affected area once or twice daily; oral rinse: 10 mL of 0.05% solution for 30 seconds twice daily (dilute 15 mL of 1% solution in 15 mL water if using concentrate).
Apply 5 mL to wet skin, lather, and rinse thoroughly after 1 minute. For preoperative showering, use 5 mL twice daily for 2 days before surgery. For surgical scrub, brush 5 mL for 2 minutes, then rinse. For hand wash, use 5 mL for 15 seconds.
None Documented
None Documented
Clinical Note
moderateLofexidine + Etacrynic acid
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Etacrynic acid."
Clinical Note
moderateLofexidine + Furosemide
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Furosemide."
Clinical Note
moderateLofexidine + Bumetanide
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Bumetanide."
Clinical Note
moderateLofexidine + Unoprostone
Terminal half-life is approximately 14 hours, supporting twice-daily dosing for maintenance of therapeutic levels.
Not applicable due to negligible systemic absorption; topical application results in skin retention with minimal systemic exposure.
Primarily renal (unchanged drug and metabolites); approximately 70% excreted in urine, 30% in feces.
Renal: <1% unchanged; fecal: >99% as chlorhexidine; biliary: negligible.
Category C
Category C
Antiseptic
Antiseptic
"Lofexidine may increase the hypotensive activities of Unoprostone."